continu expect underpin
posit trend rate bullish outlook
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research sep
estim aug
price data
rate updat
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
spent decad posit leader
healthcar servic acquisit caremark
omnicar aetna defin strateg direct
combin top-tier pbm pharmaci manag care
franchis form three pillar think posit firm
better compet consolid healthcar servic sector
next year cost advantag underli network
effect support firm excess econom return
set strengthen integr aetna continu think
cost sale synergi like exceed initi expect
firm begin serv custom lower all-in cost
rival increas attract combin medic
said think investor increasingli cautiou
evalu potenti issu aris transact
high price paid signific debt incur increas
oper risk otherwis larg stabl franchis
view follow write-down omnicar due
poor financi perform think littl room error
investor eye aetna acquisit complex
accentu increas focu washington toward
chang current drug price paradigm open door
potenti market disrupt caremark pbm industri
final expect concern around healthcar reform pick
come quarter elect cycl begin
unfold believ firm econom moat help protect
policy-driven volatil maintain large-scal
disrupt low-prob event think like
outcom would includ privat servic provid play role
polici solut nation rise cost healthcar
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
follow acquisit aetna provid even
integr healthcar servic offer member legaci
combin largest pharmaci benefit manag process nearli
billion adjust claim annual sizabl pharmaci oper
manag care organ roughli million member put firm
stronger foot within payer industri posit better lower
overal cost client
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
maintain per share fair valu estim
valuat impli time updat
estim adjust earn ebitda
respect firm appear under-valued despit
forecast
larg reflect continu
headwind long pressur firm segment
retail segment forecast overal revenu growth
set averag annual come five year
driven growth store count same-stor comp
averag midsingl digit bulk driven
script volum persist headwind
prescript reimburs pharmaci model
approxim basis-point step-down segment margin
associ weak compani omnicar
institut pharmaci subsequ improv
margin structur busi
pbm expect revenu grow annual
clip driven growth claim off-set price pressur
mail order network pharmaci channel
consequ on-going price headwind assum
gross margin oper profit per claim
continu declin rate roughli per year
leav segment oper margin histor trough
termin forecast year
final aetna expect posit sale environ
underpin combin medic pharmaci benefit
gener membership growth
time assum segment margin structur
somewhat defend help manag outlin
opportun around cost synergi associ
assumpt result consolid revenu growth
annual consolid
ebitda margin remain near forecast
period follow debt reduct next two year
assum return share repurchas help gener
roughli ep growth long run
given scale divers oper give
bull-cas scenario assum firm abl grow
firm-wide revenu rate roughli basi point ahead
base-cas expect specif bulk
upsid revenu forecast driven manag
price pressur across enterpris script price
pharmaci pbm face shallow declin
base case model addit view margin
pressur within firm retail pbm segment
manag less pronounc declin
busi insur oper assum modest
margin expans integr synergi come ahead
expect oper expens growth fall
margin expand roughli basis-point forecast
period result fair valu estim per share
time estim adjust ep ebitda
respect
bear case outlook isnt absolut worst-cas
scenario think reason encapsul
on-going weak perform compani
instanc normal revenu growth enterpris fall
slightli ahead annual also assum price
margin pressur firm three busi
result segment margin emb trough-lik
assumpt perpetu consolid ebitda margin
compani fall roughli basis-point
weakest
profit experienc firm decad
expect fair valu estim fall per
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
caremark pbm
driven pharmaci relationship patient
compani dispens one quarter prescript
fill outsid hospit help support econom
profit leverag fix cost creat synergi
order creat
cost-advantag pharmaci network within pbm
segment firm clear number one adjud
nearli billion adjust script annual addit
pbm abil consolid buy power help receiv
discount pharmaci drug manufactur
client caremark perenni low-cost
provid due size relationship pharmaci
locat view histor uniqu
combin asset think
leverag ad aetna mix pbm industri
consolid three major player
annual retent rate typic establish
three-year servic contract plan employ client
think establish weak switch cost
busi howev convinc moat
sourc would stand absent cost advantag
think strongli defin competit advantag
industri
combin pbm retail pharmaci help
creat uniqu offer help keep cost
pbm client creat valu enterpris
instanc mainten choic offer give member
option fill script mail order pharmaci
retail locat cost mail order script
help keep patient network regardless
prefer dispens method keep cost
plan sponsor think similar synergi emerg
aetna minuteclin asset own
think chang plan design encourag patient
seek minuteclin care low-acu ailment
ultim creat benefit patient
plan sponsor lower cost across board
share impli time estim adjust
ep ebitda respect
support scale-deriv cost advantag aid firm
maintain econom profit time
strateg addit aetna creat meaning cost
synergi also improv compani firm-wide
product offer combin entiti close
resembl asset mix wide-moat
view right path compani pursu
integr medic pharmaceut benefit
maintain access low-cost site care seem
direct path toward reduc cost care
client appear well way toward build
franchis focus opportun
three busi segment quit uniqu
think three reli cost advantag support
narrow econom moat pharmaci busi
front-of-stor retail busi somewhat undifferenti
like no-moat bulk segment revenu
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
manag intend remodel exist
locat initi geographi higher concentr
aetna member order cater special
patient need think logic extens
strategi compani invest minuteclin
step recent year remain signific
opportun remodel exist store expand urgent
care footprint alreadi largest retail clinic chain
wide margin market share clinic count
recent addit aetna insur asset also help
support narrow moat view contend
profit back cost advantag network effect
aetna repres fifth
measur premium written like third
fourth largest membership given sizabl fee-bas
enrol mix advantag thought two
way relat back size insur book
busi first larger membership base allow
greater central fix cost leverag increas profit
potenti margin member overal enterpris
second larger membership base allow greater
negoti leverag versu provid insur
need creat plan network allow lower medic
cost per member opportun lower premium
improv benefit offer secur enrol growth
rare instanc healthcar system focus build
local scale shift balanc power
relationship given much higher
level
concentr found industri larg think
scale frequent tip insur favor
network effect also play intertwin role
patient payer provid incumb plan
enrol grow relationship three
entiti becom valuabl time patient
becom rel afford plan invest
broader swath benefit member payer
expand enrol allow greater per-memb
profit attract offer either
better price entic benefit packag
provid particip expand plan network
provid access greater patient volum key
compon profit busi high fix cost
short run dynam creat barrier entri
would-b competitor put togeth attract
price provid network new geographi prohibit
difficult without membership pool vice versa
think sourc present aetna
less convinc network effect moat sourc would stand
support econom profit
enterpris like weak network effect
associ retail pharmaci busi appear
meaning less moatworthi network
associ manag care express script exclus
walgreen loss expect
along loss network statu prime
therapeut suggest us pharmaci
network provid less overal valu compar
provid relationship manag care somewhat
intuit patient like much indiffer
fill prescript either walgreen
would switch primari care
provid due network disput
think pursu right strategi build
integr servic provid abl add
valu client sharehold cross-sel medic
pharmaci benefit provid low-cost retail mail
drug dispens get better util
urgent care asset aetna acquisit put
equal foot industri leader
give firm compel combin asset help
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
period price asset rel high
leav consolid return invest capit
margin ahead firm cost capit howev
think return exclud goodwil indic
firm organ return increment capit go forward
metric consist mid high teen leav us
confid moat trend assess
lower cost care patient plan sponsor
think underli moat sourc attribut
strengthen result strateg
reshap follow acquisit aetna posit
exist cost advantag like improv
gain greater control integr cost medic
pharmaceut servic sell plan employ
sponsor opportun increas narrow-network
util within pharmaci improv site-of-car usag
minuteclin
combin cost
pharmaceut medic benefit integr
cost-sel initi creat compel case
strengthen competit posit next five year
addit suggest network effect like
arent widespread enough support narrow moat rate
isol think network effect associ
pharmaci medic benefit manag like
strengthen aetna caremark come togeth
umbrella extent pharmaci
minuteclin asset see increas util aetna
plan design think valu network
end patient plan sponsor like grow alongsid
member particip network success failur
strategi depend well convinc
plan sponsor take restrict access order
legaci busi seen lower return
capit insurance-focus peer due
higher capit intens associ retail pharmaci
busi adjust leas oblig also
note invest capit growth larg driven
acquisit think value-addit
enterpris acquisit caremark
omnicar pharmaci aetna
account nearli net invest capit growth
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
oth firm combin aetna put
compani much attract competit
posit industri move toward prefer
integr servic offer
ocv ownership largest nation pbm provid
substanti negoti
leverag cost
advantag claim process allow best-
oinvestor benefit meaning cost
sell synergi associ combin
lead medic benefit busi largest
pbm retail pharmaci network countri
orec polici initi suggest exist
price paradigm drug distribut may risk
oth bulk insur membership growth
come year stem cohort lower-margin
headwind insur profit
ohealthcar reform like recur topic
throughout upcom elect cycl
could creat increas stock volatil pose real
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
financi posit remain manag
take roughli billion increment debt acquir
aetna think manag capit prioriti worth
watch close follow transact close
late estim firm pro-forma leverag ratio
stood north time versu histor leverag rang
time manag outlin de-lever
path believ achiev compani
shoot gross leverag around time
reach goal manag expect
maintain current dividend level refrain share
repurchas reach leverag goal though
anticip return regular dividend growth buy-back
given scale divers oper give
medium uncertainti rate follow close aetna
acquisit compani ownership lead
footprint top insur help de-risk volatil
underli cash flow increas opportun
firm find cost revenu synergi
segment time said regulatori risk remain
ever-pres healthcar payer provid
administr push increas transpar
healthcar marketplac particularli relat drug
channel pose potenti risk firm pbm retail
pbm rebat give us comfort firm abil
weather potenti chang
structur chang price system throughout drug
distribut would like creat headwind growth
profit shorter term hand
encourag opportun compani marri
newli acquir insur asset lead pbm
win new busi serv insur client
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
overal lower price point think increas
competit firm offer like modestli
improv sticki client relationship
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
repres date owner name posit common share held report holder issuer
share
fund
share
fund
although intend keep eye on-going capit
omnicare-rel write-down larg outflow aetna
said think ceo larri merlo done
otherwis admir job lead busi sinc
pharmacist train merlo involv
sinc instrument firm transit
true healthcare-focus organ think
aetna transact like defin time ceo
expect success importantli mani key aetna
leader stay follow transact includ
firm presid karen lynch lead busi unit
former compani ceo mark bertolini join
board director
addit strong leadership team enterpris
think board put place strong compens
program align incent manag
sharehold bulk merlo compens driven
equiti incentive-bas award comprehens
set goal think consist build
intrins valu firm annual cash bonus tie
firm-wide oper profit along custom satisfact
measur pbm retail segment equiti
grant focus three-year measur return net
asset similar focu return capit rel
total sharehold return addit board recent
introduc perform stock unit vest three
year tie ebitda target
signific factor assess
appreci firm polici separ role board
chairman ceo
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
outlook manag includ risk
valuat attract across board aug
took detail look managed-car industri
came away confid posit outlook space
manag care remain attract industri
allow format sizabl econom moat
protect strong return capit almost everi corner
sector compani built advantag busi
model around monthli premium fee gener
recur revenu consolid past decad
allow competit remain ration despit
attract qualiti group trade modest discount
broader market reflect investor concern
futur healthcar polici regul unit
headlin domin variou democrat
parti polici propos medicar
would overhaul healthcar industri addit
manag care wrestl propos regulatori action
put forward trump administr so-
call rebat rule think medicar
function similar polici unlik next decad
administr abandon rebat rule earlier
year mark win industri valuat space
compress result heighten concern
market particip regard action think
investor long-term invest horizon stand
benefit own moatworthi firm favor
price integr servic offer unitedhealth
group make favorit among
five firm cover current trade discount
dcf-deriv fair valu estim
uncertainti like persist
gener elect cycl think group averag
valuat level roughli time earn emb
sizable-enough margin safeti warrant posit
detail analysi industri
assess potenti polici implic pleas see
risk manag creat opportun
moatworthi firm sizabl discount
bull case remain intact result
report second string strong quarter
follow acquisit aetna late updat
model contempl better-than-expect perform
to-dat manag modestli higher ep outlook
year forese substanti
chang per share fair valu estim
narrow-moat name remain territori current
trade near time higher earn outlook -- share
remain attract opportun view
saw last quarter retail pharmaci segment
continu post better-than-anticip growth led
same-stor script volum expand firm
expand particip pharmaci benefit manag
narrow network offer help acceler script
growth last year half notabl front store
sale also acceler nice nearli same-
store basi adjust calendar varianc versu last
year help somewhat extend flu season
pbm script growth line
expect although segment margin held much
better origin expect per-script profit
expand modestli year date despit initi
onboard volum -- assum mid-
single-digit declin year
manag care franchis continu perform well
overal medic enrol continu grow modestli
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
first quarter segment geograph
expans medicar advantag marketplac
continu propel membership higher
busi post medic loss ratio quarter
consist expect although
year-to-d figur help modest favor
reserv develop overal full-year result track
modestli ahead initi estim well within
manag initi outlook call
view compani earli post-merg result
continu underscor posit moat trend rate
combin entiti integr aetna add cost
advantag underpin narrow econom moat
profit busi segment outpac
expect help realiz synergi led
earn beat roughli compar
estim manag revis ep outlook full
year impli higher-than-anticip third quarter
lower project fourth quarter given season
pattern busi overal approxim
midpoint year look somewhat conserv rel
result thu far surpris see
addit upsid come month
last quarter highlight weaken retent rate
pbm on-going sell season
potenti caus concern time howev
pleas see manag report billion
improv net new busi compar figur
report june analyst day help grow
new win improv client retent last two
final outlook pbm industri larg
somewhat de-risk administr juli decis
abandon depart human servic
propos polici chang drug rebat practic pleas
see report rebat rule dead suppli chain benefit
drug firm pressur in-depth review
industry-specif effect unexpect shift
first report juli axio trump administr
plan final propos rule alter flow
drug rebat purchas medicar part plan
rule would chang busi model
pharmaci benefit manag requir negoti
discount pass directli beneficiari
point sale rather use mechan lower
cost insur plan overal led ralli
pbms/insur distributor drug stock sank
investor wonder presid donald trump focu
turn next take rebat reform tabl put
pressur congress particularli bipartisan senat
financ committe team chuck grassley ron wyden
reveal drug-pric packag month stand
chanc pass chamber potenti reform
like reduc cost medicar patient also look
modest payer drug firm
think remain propos review
budget offic -- medicar part intern price
index -- unlik implement even final
congress power block rule judici review
could find massiv demonstr overextens
author center medicar medicaid
innov cmmi
altern expect senat drug price packag
could includ part reform also includ cap
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
out-of-pocket spend medicar part anticip
propos would see widespread support
policymak result higher likelihood
success think chang would manag
drug firm effect achiev bipartisan
polici goal lower healthcar cost american
addit detail analysi effect
rebat rule elimin pleas see report rebat
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
